U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"If you build a better mousetrap, you will catch better mice."

George Gobel

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Inventor: Eyal S. Ron


Address: Lexington, MA
No. of applications: 15
Last application issue date: 03/01/2012

Application No.Application TitleIssue Date
20120052151METHODS AND COMPOSITIONS FOR WEIGHT MANAGEMENT AND FOR IMPROVING GLYCEMIC CONTROL
The present invention provides methods, compositions and modified foods and foodstuffs useful for weight management and glycemic control....
03/01/2012
20110306669RAPID ONSET AND SHORT TERM MODAFINIL COMPOSITIONS AND METHODS OF USE THEREOF
Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, ale...
12/15/2011
20110280922DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES
The invention relates to a therapeutic device for the delivery of therapeutic agents, e.g. a peptide such as leuprolide, via the vagina to a female mammal. In some embodiments, the invention also relates to methods for the treatment of obesity and eating disorders, diab...
11/17/2011
20110021729Methods of Purifying Poly(Styrene-co-Maleic Anhydride/Acid)
The present invention relates in part to poly(styrene-co-maleic anhydride/acid) copolymers having high purity, for example, having low amounts of maleic acid, maleic anhydride, and/or styrene. The present invention also relates in parts to methods of purifying poly(styr...
01/27/2011
20100273844PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING MIGAINES
The present invention provides a method for treating or preventing one or more types of migraines by administering a monoamine oxidase inhibitor, preferably isocarboxazid, in a rapid-release formulation. The present invention also provides a pharmaceutical composition s...
10/28/2010
20090311235Use of Polymeric Materials with Other Substances for Improved Performance
Methods of enabling or improving the ability of a hydrogel to swell in the stomach of an animal and/or increasing the amount of time said hydrogel remains swollen in the stomach are described herein. In one embodiment, a polymer is administered in combination with one o...
12/17/2009
20080248017METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments f...
10/09/2008
20080145424Sustained release L-arginine formulations and methods of manufacture and use
The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in part, on the discovery that administering to a subject a formulation compri...
06/19/2008
20080102102Methods And Compositions For Decreasing Saliva Production
The invention provides methods and compositions comprising an anti-cholinergic agent for decreasing saliva production and treating sialorrhea....
05/01/2008
20070196433Methods and devices for the sustained release of multiple drugs
The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments f...
08/23/2007
20060029668Sustained release L-arginine formulations and methods of manufacture and use
The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in part, on the discovery that administering to a subject a formulation compri...
02/09/2006
20050287210Sustained release L-arginine formulations and methods of manufacture and use
The present invention provides methods and formulations for the treatment and prevention of cerebrovascular and cardiovascular diseases and disorders. The present invention is based, at least in part, on the discovery that administering to a subject a formulation compri...
12/29/2005
20050288372Methods of treating various conditions by administration of sustained released L-Arginine
The present invention provides methods for using L-arginine formulations, such as sustained release formulations, for various indications, including lowering triglyceride levels, inducing thermogenesis, weight loss and treatment and prevention of obesity and obesity rel...
12/29/2005
20050288373Methods of treating various conditions by administration of sustained release L-arginine
The present invention provides methods for using L-arginine formulations, such as sustained release formulations, for various indications, including lowering triglyceride levels, inducing thermogenesis, weight loss and treatment and prevention of obesity and obesity rel...
12/29/2005
20050106269Increasing cerebral bioavailability of drugs
A method and compositions are provided for increased cerebral bioavailability of blood-born compositions by administering the composition of interest while increasing production of NO by eNOS, especially by administering L-arginine, by administering agents that increase...
05/19/2005
 
Sign InRegister
Username  
Password   
forgot password?